Did you know that peripheral arterial disease (PAD) is asymptomatic in 50-75% of cases(1)? This is an alarming statistic, especially when we consider that PAD is a strong risk factor for cardiovascular disease (the leading cause of death worldwide).
Considering also that 25% of cases of sudden cardiac death have no prior symptoms or appreciable risk factors(2), the need for early detection of PAD becomes clear.
As well as its link to mortality, PAD is a leading cause of morbidity - PAD can lead to foot ulceration, which can lead to amputation - with devastating physical and emotional impacts on the individual as well as significant financial implications for the health system.
Currently, PAD is underdiagnosed, hence undertreated(3). There is a compelling need for more targeted screening in at-risk populations to reduce morbidity and mortality rates in people with PAD.
One of the reasons for underdiagnosis is inadequate screening due to a lack of knowledge among Health Professionals of which assessments are most effective in making a diagnosis of PAD. Commonly used tests for PAD have limited sensitivity in the most at-risk populations (4). Clinical assessments range from simple observation to more complex ABI (ankle-brachial index). Research supports the use of some, but not all of these assessment techniques. Below are some of the most common:
Another barrier to effective screening is that certain guidelines don’t reflect the latest evidence.
With all this in mind, I’m sure you’re keen to learn more. Join us on Monday, August 6th at 7.30PM (AEST) for a one-hour webinar, where our expert presenter Dr Sylvia McAra will share a best-practice approach to assessing PAD using evidence-based clinical tests.
This is a multidisciplinary webinar for Podiatrist, GPs and Nurses. Click here to read more and enrol.
References:
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreFrom the 1st Nov 2025, updates to the MBS affect all GPs providing services related to long-acting reversible contraceptives. This FastTrack will get you up to date on which items attracted an increased rebate, the new item number, and how to avoid common compliance pitfalls. 30mins each of RP and EA CPD available with the quiz.
GPs are often faced with the presentation of a red, sticky eye. Even without a slit lamp, there are key points in your clinical assessment that can help to differentiate the causes of conjunctivitis and guide the appropriate management. Read the fact sheet then claim 30mins each of RP and EA CPD with the quiz.
Co-billing and split billing are often a source of confusion for many GPs. This FastTrack clearly defines these two methods of billing, including examples, explanations of when it is and isn’t appropriate to co- or split bill, and common compliance pitfalls. 30 mins each RP and EA available with the quiz.